Halma plc Acquires Lamidey Noury for £42 Million

Halma plc, a global technology company focused on life-saving solutions, has completed the acquisition of Lamidey Noury Medical, a French manufacturer of electrosurgical devices, for £42 million. This acquisition marks a strategic expansion into advanced minimally invasive surgical products for Halma's healthcare sector. Lamidey Noury, established in 1947 and based near Paris, supplies its innovative medical devices to over 60 countries. The operation was financed through Halma's existing facilities and completed on a cash- and debt-free basis. The firm reported an unaudited revenue of approximately £11.4 million for the year ending October 2024, with an EBIT margin exceeding Halma's target range. Lamidey Noury will continue operating under its existing management as a standalone entity within Halma, enhancing its capabilities in treating urological and gynecological diseases. CEO Marc Ronchetti emphasized the acquisition's role in improving healthcare efficiency, while Lamidey Noury's President, Guillaume Noury, expressed optimism about leveraging Halma’s global reach for accelerated growth.